期刊文献+

替米沙坦对胰岛素抵抗大鼠糖脂代谢和抵抗素表达的影响 被引量:6

下载PDF
导出
摘要 目的观察替米沙坦对高脂饮食诱导的胰岛素抵抗大鼠糖脂代谢和抵抗素表达的影响。方法选择36只W istar大鼠分为NC组12只和高脂组24只,6周后高脂组大鼠分为替米沙坦组(T)和高脂对照组(HF)各12只,4周后测定体质量、附睾脂肪重量、FPG、FINS、FFA和血脂;高胰岛素—正常葡萄糖钳夹技术评价胰岛素敏感性;RT-PCR法检测附睾脂肪组织抵抗素mRNA的表达。结果与HF组比较,替米沙坦治疗后大鼠的体质量、附睾脂肪重量、FINS、FPG、TG、FFA、LDL-C明显降低,HDL-C、抵抗素mRNA表达水平和胰岛素敏感性增强(P<0.05或P<0.01)。结论替米沙坦能减轻IR大鼠的体质量和内脏脂肪重量,改善糖脂代谢紊乱,上调附睾脂肪组织抵抗素mRNA的表达,提高胰岛素敏感性。
出处 《山东医药》 CAS 北大核心 2009年第24期30-32,共3页 Shandong Medical Journal
  • 相关文献

参考文献9

  • 1Benson SC, Pershadsingh HA, Ho CI, et al. Identification of telmisartan as a unique angiotensin Ⅱ receptor antagonist with selective PPAR-gamma-modulating activity [J]. Hypertension, 21304,43(5) :993-1002.
  • 2Vitale C, Mercuro G, Castiglioni C, et al. Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome [ J ]. Cardiovasc Diabetol, 2005,4:6.
  • 3Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes [J]. Nature, 2001,409(6818) :307-312.
  • 4Yamauchi T, Waki H, Kamon J, et al. Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes [J]. J Clin Invest, 2001,108(7) :1001-1013.
  • 5Milan G, Granzotto M, Scarda A, et al. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss[J]. Obes Res, 2002,10 ( 11 ) : 1095-1103.
  • 6Way JM, Gorgun CZ, Tong Q, et al. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome pmliferator-activated receptor gamma agonists [ J]. J Biol Chem, 2001,276(28) :25651-25653.
  • 7Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance [J]. Trends Endocrinol Metab, 2002,13 ( 1 ) : 18-23.
  • 8Araki K, Masaki T, Katsuragi I, et al. Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice [ J]. Hypertension, 2006,48 ( 1 ) :51-57.
  • 9Derosa G, Fogari E, D'Angelo A, et al. MetaboLic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone [J]. J Clin Pharm Ther, 2007,32(3) :261-268.

同被引文献60

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部